marketnews

Unicycive Calls it Quits: Say Goodbye to Their Stock Offering!

Unicycive Announces Termination of “At-The-Market” Offering of Shares of Co… Goodbye, ATM Offering! So long, farewell, ATM Offering! Unicycive Therapeutics, Inc. has decided to bid adieu to its “at-the-market” equity offering program. The company made the announcement that it’s pulling the plug on this program with JonesTrading Institutional Services, LLC as the sales agent. But…

Read More

Revolutionizing Breast Cancer Treatment: Insilico Medicine’s AI-Powered Candidate Takes Aim at KAT6A for ER/HER2 Therapy

Insilico Medicine Nominates Preclinical Candidate Targeting KAT6A New York, Dec. 27, 2022 (GLOBE NEWSWIRE) — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company’s drug discovery team has nominated a preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy utilizing its end-to-end Pharma.AI platform. The Company has…

Read More

Breaking News: MSP Recovery to Rebrand as LifeWallet – A Nationally Recognized Brand!

Breaking News: MSP Recovery to Rebrand as LifeWallet – A Nationally Recognized Brand! Description: CORAL GABLES, Fla., Dec. 22, 2022 (GLOBE NEWSWIRE) — MSP Recovery, Inc. (“MSP” or the “Company”) (NASDAQ: MSPR) (NASDAQ: MSPRW), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced the Company will begin doing business as…

Read More

Celebrating Success: Pennsylvania Skill Commends State’s Gambling Industry for Impressive November Profits

Celebrating Success: Pennsylvania Skill Commends State’s Gambling Industry for Impressive November Profits Harrisburg, PA, Dec. 21, 2022 (GLOBE NEWSWIRE) — Pennsylvania Skill Powered by Pace-O-Matic congratulated the Pennsylvania gambling industry on generating $452.3 million in revenue last month, which is nearly a 4.6% increase over November 2021. As we near the end of the year,…

Read More

Discover the Latest Breakthrough in Parkinson’s Disease Research: Zhittya Genesis Medicine Hosts Free Zoom Webinar and Shares 6-Month Patient Follow-Up Report

Zhittya Genesis Medicine Unveils Breakthrough Parkinson’s Disease Treatment Introduction On December 19, 2022, Zhittya Genesis Medicine, Inc., a private biotechnology company, made a groundbreaking announcement regarding their latest research on treating Parkinson’s disease. The company revealed that they will be hosting a free webinar on December 20, 2022, to present their findings on a first-in-human…

Read More

Digital Pharma East 2022: The Ultimate Gathering of Pharma, Biotech, and Healthcare Leaders – Over 1200 Strong!

Questex’s Digital Pharma East 2022 Delivers Largest Attendance in the Conference’s History Exciting News from the Premier Marketing Event for Life Sciences New York, Dec. 19, 2022 (GLOBE NEWSWIRE) — Questex’s Digital Pharma East, the must-attend conference for anyone in the life sciences industry, just wrapped up its 2022 event with a bang! This year’s…

Read More